Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
Metalloprotease
G-alpha
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Transporter
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
DNA
RNA
Compound
Inorganic ion
Predicted metabolite or user's structure
Reaction
Generic receptor
GPCR
Receptors with enzyme activity
Mitochondria
EPR
Golgi
Nucleus
Lysosome
Peroxisome
Cytoplasm
Extracellular

Normal process
Pathological process
Binding
Cleavage
Covalent modifications
Phosphorylation
Dephosphorylation
Transformation
Transport
Catalysis
Transcription regulation
MicroRNA binding
Competition
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

G-protein signaling G-Protein alpha-s signaling cascades


Log In to Post A Comment

G-protein signaling G-Protein alpha-s signaling cascades

G-Protein alpha-s signaling cascades

G-protein alpha-s coupled receptors interact with trimericG-protein alpha-s/ beta/gamma causing exchange of GDP for GTP bound toG-protein alpha-s subunits, followed by dissociation of the beta/gammaheterodimers.

G-protein alpha-s can directly stimulate activity of v-srcsarcoma (Schmidt-Ruppin A-2) viral oncogene homolog ( c-Src ) and Adenylatecyclase 1 ( Adenylate cyclase type I ) .

Regulators of G-protein signaling (RGS) proteins are GTPase-activatingproteins (GAPs) that attenuate signaling by heterotrimeric G proteins. Regulator ofG-protein signaling 2, 24kDa ( RGS2 ) directly binds with G-protein alpha-sand selectively inhibits G protein alpha-s function [1].

G-protein alpha-s activates all isoforms of adenylate cyclases.After stimuli, Adenylate cyclase type I increases levels of cAMP in thecell and activates Protein kinase, cAMP-dependent ( PKA ) inactive complex (PKA-reg (cAMP-dependent) - PKA-cat (cAMP-dependent) ), which results in PKAactivation [2].

PKA regulates activity of different proteins participating in various cellprocesses.

PKA-cat (cAMP-dependent) phosphorylates and stimulates cAMP responsive elementbinding protein 1 ( CREB1 ) [3]. Phosphorylation of phosphodiesterase4A, cAMP-specific ( PDE4A) by PKA-cat (cAMP-dependent) increasesPDE4A activity and catalyzes cAMP hydrolysis [4]. PKA-cat(cAMP-dependent) also phosphorylates Ryanodine receptor 1 ( RYR1 ) and,thereby, activates a calcium (Ca2+) release channel [5]. 

On the other hand, phosphorylation by PKA inhibits Glycogen synthasekinase-alpha/beta ( GSK3alpha/beta ) activity [6], reduces theaffinity of Adducin 1 ( Alpha adducin ) for actin complexes, and blocks the actionof Anaphase-promoting complex (APC), which regulates mitotic progression andchromatin assembly [7].

Other targets for cAMP are guanine nucleotide exchange factors for smallGTPases. cAMP binds guanine nucleotide exchange factor Rap guanine nucleotideexchange factor (GEF) 2 ( PDZ-GEF1 ) and activates Mitogen-activated proteinkinase kinases 1 and 2 ( MEK1(MAP2K1), MEK2(MAP2K2) )/ Mitogen-activatedprotein kinases 1-3 ( ERK1/2 ) pathway via v-Ha-ras Harvey rat sarcoma viraloncogene homolog ( H-RAS )- v-raf-1 murine leukemia viral oncogene homolog 1 (c-Raf-1 ) regulation [8].

Other cAMP-binding guanine nucleotide exchange factors Rap guanine nucleotide exchangefactor (GEF) 4 and 3 ( cAMP-GEFII, cAMP-GEFI ) promote cell proliferationvia RAP1A, member of RAS oncogene family ( RAP-1A )/ v-raf murine sarcoma viraloncogene homolog B1 ( B-RAF )/ MEK1(MAP2K1), MEK2(MAP2K2)/ERK1/2 pathway and inhibit c-Raf-1 signaling [9].